Chinese scientists, with the aim of enhancing leukemia treatment, have developed a kind of "double-sided tape" that helps the ...

Engineered immune cells targeted and reduced the toxic protein plaques that drive Alzheimer’s disease in a recent study.

In MS trials, investigators are steering those cells toward B‑cell populations that appear to be driving inflammation.

A handful of small, early-stage clinical trials are investigating whether CAR-T therapy can improve symptoms in multiple ...

I recently found out that my aunt was diagnosed with cancer and may need chemotherapy. When I think of chemotherapy, I ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells ...

The MarketWatch News Department was not involved in the creation of this content. Strategy May Bolster Blood Cancer Therapy and Move HIV Research Closer to a Cure BRONX, N.Y., March 13, 2026 ...

The approach relies on a specially engineered scaffold that links three naturally occurring cytokines known to promote immune memory.

Giahan Tang thought she was finally finding stability after college when unusual symptoms led to a shock diagnosis of stage 4 diffuse large B-cell lymphoma After an ER visit initially blamed on an ...

Researchers in upstate New York are hopeful the work they’re doing may soon lead to new therapies for more cancer ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...

The therapeutic landscape for cutaneous T-cell lymphoma (CTCL) is undergoing a significant shift with the emergence of denileukin diftitox (Lymphir), the first systemic treatment ...